| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 106,935 | 113,894 | 104,778 | 187,348 | | Cost of Revenue | 7,866 | 7,635 | 7,347 | 9,753 | | | Gross Profit | 99,069 | 106,259 | 97,431 | 177,595 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,686 | 16,928 | 18,322 | 23,404 | | Non Recurring |
-
|
-
|
-
| 232,683 | | Others | 46,040 | 45,502 | 42,526 | 61,479 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35,343 | 43,829 | 36,583 | (139,971) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,122 | 98 | (3,193) | (15,967) | | Earnings Before Interest And Taxes | 36,539 | 44,085 | 33,467 | (155,491) | | Interest Expense | 1,290 | 2,260 | 2,154 | 2,926 | | Income Before Tax | 35,249 | 41,825 | 31,313 | (158,417) | | Income Tax Expense | 9,138 | 10,978 | 8,499 | (28,678) | | Minority Interest | (270) |
-
|
-
| 40,695 | | | | Net Income From Continuing Ops | 26,150 | 30,847 | 22,814 | (89,044) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,841 | 30,847 | 22,814 | (89,044) | | Preferred Stock And Other Adjustments | 14 | (512) | 498 |
-
| | | Net Income Applicable To Common Shares | $25,855 | $30,335 | $23,312 | ($89,044) |
|
0.51% Nasdaq 
Income Statement
